1. Reversal of high-glucose-induced transcriptional and epigenetic memories through NRF2 pathway activation.
- Author
-
Wilson-Verdugo M, Bustos-García B, Adame-Guerrero O, Hersch-González J, Cano-Domínguez N, Soto-Nava M, Acosta CA, Tusie-Luna T, Avila-Rios S, Noriega LG, and Valdes VJ
- Subjects
- Humans, Hyperglycemia metabolism, Hyperglycemia genetics, Chromatin metabolism, Chromatin genetics, Endothelial Cells metabolism, Endothelial Cells drug effects, Transcription, Genetic drug effects, Gene Expression Regulation drug effects, Isothiocyanates pharmacology, Human Umbilical Vein Endothelial Cells metabolism, Human Umbilical Vein Endothelial Cells drug effects, Sulfoxides pharmacology, NF-E2-Related Factor 2 metabolism, NF-E2-Related Factor 2 genetics, Glucose metabolism, Epigenesis, Genetic drug effects, Signal Transduction drug effects, Signal Transduction genetics
- Abstract
Diabetes complications such as nephropathy, retinopathy, or cardiovascular disease arise from vascular dysfunction. In this context, it has been observed that past hyperglycemic events can induce long-lasting alterations, a phenomenon termed "metabolic memory." In this study, we evaluated the genome-wide gene expression and chromatin accessibility alterations caused by transient high-glucose exposure in human endothelial cells (ECs) in vitro. We found that cells exposed to high glucose exhibited substantial gene expression changes in pathways known to be impaired in diabetes, many of which persist after glucose normalization. Chromatin accessibility analysis also revealed that transient hyperglycemia induces persistent alterations, mainly in non-promoter regions identified as enhancers with neighboring genes showing lasting alterations. Notably, activation of the NRF2 pathway through NRF2 overexpression or supplementation with the plant-derived compound sulforaphane, effectively reverses the glucose-induced transcriptional and chromatin accessibility memories in ECs. These findings underscore the enduring impact of transient hyperglycemia on ECs' transcriptomic and chromatin accessibility profiles, emphasizing the potential utility of pharmacological NRF2 pathway activation in mitigating and reversing the high-glucose-induced transcriptional and epigenetic alterations., (© 2024 Wilson-Verdugo et al.)
- Published
- 2024
- Full Text
- View/download PDF